Ars Pharmaceuticals Inc (SPRY)
Deferred Revenue
$535.00K
Quarterly · Period ending: · USD
SPRY Deferred Revenue
Latest reported$535.00Kperiod ending
Latest reported$535.00Kperiod ending
SPRY Quarterly Deferred Revenue ($0.00 → $535.00K)
Quarterly deferred revenue
High-resolution chart · PNG
SPRY deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 535,000 | |
| 757,000 | |
| 609,000 | |
| 0 | |
| 746,000 | |
| 540,000 | |
| 557,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10,000 | |
| 0 | |
| 0 | |
| 344,000 | |
| 0 | |
| 1,457,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |